These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6177958

  • 1. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP, Hill P.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [Abstract] [Full Text] [Related]

  • 2. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 3. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 4. Coronary heart disease and the treatment of hypertension: impact of diuretics on serum lipids and glucose.
    Ames RP.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S466-73. PubMed ID: 6208413
    [Abstract] [Full Text] [Related]

  • 5. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
    Samuelsson O, Pennert K, Andersson O, Berglund G, Hedner T, Persson B, Wedel H, Wilhelmsen L.
    Lakartidningen; 1998 Mar 11; 95(11):1120-3. PubMed ID: 9542820
    [Abstract] [Full Text] [Related]

  • 6. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    J Cardiovasc Pharmacol; 1987 Mar 11; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [Abstract] [Full Text] [Related]

  • 7. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 11; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 8. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W.
    Z Kardiol; 1992 Jun 11; 81(6):295-302. PubMed ID: 1353932
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Jun 11; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 10. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic considerations.
    Miller NE.
    J Cardiovasc Pharmacol; 1982 Jun 11; 4 Suppl 2():S190-5. PubMed ID: 6177955
    [Abstract] [Full Text] [Related]

  • 11. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
    Holtzman E, Rosenthal T, Goldbourt U, Segal P.
    Isr J Med Sci; 1984 Dec 11; 20(12):1169-76. PubMed ID: 6519949
    [Abstract] [Full Text] [Related]

  • 12. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP, Peacock PB.
    Arch Intern Med; 1984 Apr 11; 144(4):710-4. PubMed ID: 6712367
    [Abstract] [Full Text] [Related]

  • 13. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 11; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
    Weinberger MH.
    Arch Intern Med; 1985 Jun 11; 145(6):1102-5. PubMed ID: 2860883
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG.
    Clin Ther; 1986 Jun 11; 8(5):490-509. PubMed ID: 2876774
    [Abstract] [Full Text] [Related]

  • 16. Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
    Karmakoski J, Viikari J, Rönnemaa T.
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr 11; 21(4):189-91. PubMed ID: 6862723
    [Abstract] [Full Text] [Related]

  • 17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM.
    Am Heart J; 2002 Dec 11; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [Abstract] [Full Text] [Related]

  • 18. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Dec 11; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 19. Serum lipoprotein profile under different antihypertensive therapy.
    Youssef S, Osman L, Sabbour MS.
    Int J Clin Pharmacol Res; 1992 Dec 11; 12(3):109-16. PubMed ID: 1473876
    [Abstract] [Full Text] [Related]

  • 20. The association between antihypertensive drug therapies and plasma lipid levels in the general population.
    Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A.
    J Hum Hypertens; 2001 Oct 11; 15(10):701-5. PubMed ID: 11607800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.